Inflammatory bowel disease has been reported to co-exist with other autoimmune diseases. Sjogren's syndrome is an autoimmune disorder characterized by xerostomy and/or xerophthalmy. Sjogren's syndrome occurring in IBD has been very rarely reported. A 45-year old woman diagnosed ten years ago with ulcerative pancolitis and primary sclerosing cholangitis was referred to our outpatient IBD clinic because of xerostomy but not for xerophthalmy for the previous three months. The patient had been under azathioprine maintenance treatment (2 mg/kg) and achieved long-term disease remission for the past 4 years. Patient clinical examination and laboratory tests were unremarkable. Salivary gland biopsy and complete ophthalmologic investigation were performed and the patient was diagnosed with Sjogren's syndrome. Understanding sicca manifestations in IBD is difficult since the pathogenesis of this intestinal disorder is not yet clear. Of these complex autoimmune phenomena which occur along with IBD it is quite difficult to categorize concomitant Sjogren's syndrome as primary or secondary and literature is conflicting. The possibility of Sjogren's syndrome should always be considered and properly investigated in patients diagnosed with inflammatory bowel disease who develop a constellation of constitutional sicca symptoms.
Introduction
Inflammatory bowel disease (IBD) is a disease of unknown origin which affects both sexes [1] [2] [3] and for which many factors (genetic, autoimmune, allergic, microbiological, psychological) have been suggested. IBD is a chronic systemic disorder often accompanied by extraintestinal manifestations -almost from all systems-mainly from the skin, joints, liver and the eyes. [1] [2] [3] [4] [5] Inflammatory bowel disease (IBD) has been reported to coexist with other autoimmune diseases. The relationship of IBD in the form of Crohn's disease (CD) or ulcerative colitis (UC) with other extraintestinal autoimmune phenomena has been frequently reported; however, data is still scarce as the exact mechanism(s) linking all these disorders under an umbrella of common pathogenetic mechanisms have not been clearly established. Sjogren's syndrome (SS) is an autoimmune disorder characterized by xerostomy or xerophthalmy. It may also be manifested as a generalized sicca syndrome with both xerostomy and xerophthalmy (dry eye) in patients with or without other concomitant disorders, such as primary sclerosing cholangitis. 6 Sjogren's syndrome has been associated with many of the disorders in which autoimmunity is considered likely to play a major role in pathogenesis and can be primary or secondary. 7 Criteria for secondary SS include subjective dry eye and/or dry mouth symptoms; also the presence of either one of the following: objective evidence of reduced tear formation or salivary flow rate and a positive labial gland biopsy. Sjogren's syndrome concurrently with IBD has very rarely been reported and seems to follow IBD diagnosis. 8 Herein is a report of a patient with ulcerative colitis and primary sclerosing cholangitis who was diagnosed with concomitant secondary Sjogren's syndrome.
Case report
A 45-year old woman diagnosed ten years ago with ulcerative pancolitis and primary sclerosing cholangitis was referred to the outpatient IBD clinic presenting with xerostomy though without symptoms of xerophthalmy for the three previous months. Patient was under azathioprine maintenance treatment (2 mg/kg) and had achieved long-term disease remission for the past 4 years.
Patient clinical examination and laboratory tests were unremarkable. Immunological tests showed rheumatoid factor positivity but in low titers (1/80).
Due to the severity of symptoms it was decided to further investigate the clinically suspected sicca syndrome.
Salivary gland biopsy and complete ophthalmologic investigation were performed as described previously. 3 Ophthalmological examination was negative for dry eye or any other ocular abnormality in the patient but the salivary gland biopsy was compatible with Sjogren's syndrome.
Histology of the salivary gland specimen showed diffuse lymphocyte infiltrations strongly supporting the diagnosis of Sjogren's syndrome for this patient.
Discussion
We reported herein a rare case of a patient with UC and PSC diagnosed with secondary Sjogren's syndrome, which was manifested with xerostomia but not with xerophthalmia. It is noteworthy that very few cases of IBD patients diagnosed with SS have so far been reported [ Table 1 ]. In Crohn's disease, concomitant diagnosis of SS has been reported in five patients 7,9-12 some of whom also manifest other concomitant disorders, such as Sweet's syndrome, 9 Hashimoto thyroiditis 11 and rheumatoid arthritis with systemic lupus erythematosus.
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Ulcerative colitis concurrently with SS has been reported in five cases [13] [14] [15] [16] ; some of them also manifest other concomitant disorders such as gastric autoantibodies, 14 sarcoidosis 13,14 and selective IgA deficiency. 16 Understanding sicca manifestations in IBD is difficult, since the pathogenesis of this intestinal disorder is not yet clear. On the other hand, the spectrum of disorders associated with SS is wide and the acronym TOASSUC (thyroiditis, other autoimmunity, Sjogren's syndrome, sarcoidosis, ulcerative colitis) has been suggested some years ago. 14 Of these complex autoimmune phenomena occurring along with IBD it is quite difficult to categorize concomitant SS as primary or secondary. 7 It seems that in the absence of other known primary causes of SS, the features of some cases with IBD and SS co-existence are suggestive of a direct relationship between these disorders.
Of note, secondary SS in IBD patients may also be related to treatment with sulphasalazine; immunosuppression and withdrawal from sulphasalazine may result in rapid resolution and disappearance of autoantibodies. 16 According to a six-year post-diagnostic prevalence study of SS, sicca symptoms, tear and saliva production were not decreased in IBD patients as compared to controls, indicating a lack of association between SS and inflammatory bowel disease. 17 By contrast, a recent prospective study demonstrated higher frequency of dry eye in IBD patients, as compared to the background population. 18 The above patient did not have any symptoms or findings suggestive of dry eye. The prevalence of dry eye in IBD is currently unknown but in the control population of our area the overall prevalence of dry eye is 11%, which is remarkably lower compared to that found in our cohort of IBD patients 
1 Crohn Sweet's syndrome (22%). 18 Of interest, in our cohort of IBD patients diagnosed with 'dry eyes' [ Table 2 ] was also identified, not however with Sjogren's syndrome, another female patient with ulcerative colitis, PSC and 'dry eye'.
Therapeutic options in patients with IBD and SS syndrome in terms of immunosuppression include standard immunosuppressives such as azathioprine and methotrexate and biological therapies. Azathioprine in standard doses is the basis and seems to be efficient in this group of patients; however, in Crohn's disease patients with concomitant rheumatologic comorbidity, treatment with methotrexate is also a logical approach. Infliximab was successfully used in a patient with Crohn's disease together with Sweet's and SS. 9 However, large clinical experience is lacking.
The clinical course of SS in IBD patients seems not to substantially differ from that of patients without IBD. In the great majority of cases reported so far, SS is manifested many years after the initial IBD diagnosis and its course is rather mild. Moreover, none of the reported SS-IBD patients presented any evidence of gland disease deterioration or even lymphoma diagnosis. According to our experience with 'dry eye' IBD patients, 18 the severity of 'dry eye' symptoms is independent of the IBD course and does not parallel disease exacerbations and bowel symptoms.
To conclude, we believe that the possibility of Sjogren's syndrome should always be considered and properly investigated in patients diagnosed with inflammatory bowel disease who develop a constellation of constitutional sicca symptoms.
